Effects of Fenofibrate on Adipocytokine Levels In Hypertriglyceridemic Patients
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Fenofibrate increases adiponectin levels, but reduces leptin levels
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jan 2005
Longer than P75 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2008
CompletedFirst Submitted
Initial submission to the registry
September 2, 2008
CompletedFirst Posted
Study publicly available on registry
September 3, 2008
CompletedSeptember 3, 2008
September 1, 2008
September 2, 2008
September 2, 2008
Conditions
Keywords
Study Arms (1)
fenofibrate 160 mg, placebo
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- hypertriglyceridemia
You may not qualify if:
- chronic liver disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gil Medical Center
Incheon, 405760, South Korea
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
September 2, 2008
First Posted
September 3, 2008
Study Start
January 1, 2005
Study Completion
August 1, 2008
Last Updated
September 3, 2008
Record last verified: 2008-09